Depression and Anxiety Disorders of Children and Adolescents
Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major...
Transcript of Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major...
![Page 1: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/1.jpg)
TreatmentofMajorDepressionInAdolescents
IanMGoodyerOBEMDFRCPsychFMedSciUniversityofCambridge
![Page 2: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/2.jpg)
Depressedmood
Irritability/anger
Anhedonia
Weight/appetitedisturbanceSleepdisturbance
PsychomotordisturbanceFatigue,lackofenergy,tiredness
Self-perceptionsCognitivedisturbance
Suicide
DSM:UnipolarMajorDepression
mood+4(ormore)others
Psychoticfeatures
3-4symptoms(mild);5-6symptoms(moderate);7+symptoms(severe)plusimpairment
![Page 3: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/3.jpg)
RandomisedControlledTrials:
• TreatmentofAdolescentdepressionStudy(TADS):2004.
• AdolescentDepressionandPsychotherapyTrial(ADAPT):2007.
• TreatmentofResistantDepressioninAdolescents(TORDIA):2008.
• Improvingmoodwithpsychotherapyandcognitivetherapy(IMPACT):2017.
![Page 4: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/4.jpg)
TADS:RCTDesign
2084screened1008interviewed
549Baselineassessment
Fluoxetine+CBT107(92)
FluoxetineOnlyN=109(91)
CBTOnlyN=111(87)
MedicationPlacebo
N=112(89)
MarchetalJAMA2004;292:807-820
![Page 5: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/5.jpg)
TADS: Adjusted Mean (SE) Scale Scores
MarchetalJAMA2004;292:807-820
![Page 6: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/6.jpg)
% of patients in remission by treatment group
0
1020
3040
5060
7080
comb flux CBT Pillplacebo
% response CDRS-R
N439adolescentswithMD,12weekoutcomes
![Page 7: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/7.jpg)
TADSOutcomes1YearofNaturalisticFollow-Up
MarchJetalAmericanJournalofPsychiatry2009;166:1141-1149
![Page 8: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/8.jpg)
TADS: Summary
• TreatmentwithfluoxetinealoneorincombinationwithCBTacceleratestheresponse.
• AddingCBTtomedicationenhancesthesafetyofmedication.
• Takingbenefitsandharmsintoaccount,combinedtreatmentadvisedformajordepressioninadolescents
MarchJSetalArchGenPsychiatry.200764(10):1132-43.
![Page 9: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/9.jpg)
ADAPT: Adolescent Depression and Psychotherapy Trial
510 NHS outpatients assessed
261excluded(109notdepressed,48DNA,39drugconcerns,38refused,6tooill,1previoustreatment,20other)
249:164hadabriefpsychosocialintervention2/3sessions
126 BII non-responders
211 research interview
208 randomised
85bypassedBII(34inCAMHS,29onSSRI,22urgentmedsrequired)
34improved,4refused
2 refused, 1 improved
104specialistclinicalcare+Fluoxetine20mg-60mg
104specialistclinicalcare+Fluoxetine20mg-60mg+CBT
![Page 10: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/10.jpg)
Clinician Rated Depression Scale 55
6065
7075
0 6 12 28Weeks
SSRI CBT+SSRI
Averagetreatmenteffect=1.43,95%CI-0.71,+3.52,p=0.19
GoodyeretelBMJ.2007Jul21;335(7611):142
CDRS-R
![Page 11: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/11.jpg)
Self Report Depression Symptoms- MFQ
1020
3040
0 6 12 28Weeks
SSRI CBT+SSRI
Averagetreatmenteffect=1.27,95%CI-1.26,+3.80,p=0.32
GoodyeretelBMJ.2007Jul21;335(7611):142
![Page 12: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/12.jpg)
Clinical Global Impression Over Study Period
weeks
Maximumclinicalbenefitsmaynotbeseenuntil28weeksaftertreatmentbegins
GoodyerIMetal(2008)HealthTechnolAssess.12(14):iii-iv,ix-60
![Page 13: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/13.jpg)
ADAPTSummary
• NoaddedvalueforCBTintreatingunipolardepressionoverandabovethatofspecialistclinicalcareandfluoxetine.
• Overalltreatmenteffectivenessat28weeksaround60%.
• Treatmentresistance–10%-20%
• PatientsintheTrialweremoderate-severelyill.
• Notaneffectivenesstrialforfluoxetine
![Page 14: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/14.jpg)
Treatment resistant depressions
Brent DA et al: The TORDIA Study JAMA. 2008 February 27; 299(8):
901–913
![Page 15: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/15.jpg)
TORDIA: RCT Design
334treatmentresistantpatientsnoresponseto
SSRIs@12weeks
DifferentSSRIparoxetine,citalopram,fluoxetine,20–40mgN=85
DifferentSSRI+CBTN=83
Venlafaxine(150–225mg)
N=83
Venlafaxine+CBTN=83
![Page 16: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/16.jpg)
Clinical response 12 weeks post new treatment
42
44
46
48
50
52
54
56
New SSRI NS+CBT Venlaf Ven + CBT
CGI %
N=334@entry;N=223completion;ITTanalysis(LR):CBTp=0.03qualifiedbyasitexCBTinteractionp=0.003
![Page 17: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/17.jpg)
Clickonimagetomagnify.
TORDIA:Clinicalresponse72weekspostnewtreatment
Responseapparentby6weeks.~30%-noremissionand25%relapse.
VitielloB,etalJClinPsychiatry.2011Mar;72(3):388-96
![Page 18: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/18.jpg)
TordiaSummary
• TreatmentresistancetoanSSRIcanrespondtocombinationtherapysuchasanotherSSRI+CBT.
• Venlafaxinenotamedicationofchoice.
• Responsebyabout6weekswithlittlegainfromthen.
![Page 19: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/19.jpg)
TreatmentofDepressedAdolescents2000-2018
• Severedepressionsoccurin1%-2%
• Nonremissionby12months~30%
• Treatmentnonresponserate~10%-20%
• Norobustclinicalorpsychosocialpredictorsoftreatmentresponse,resistanceorrecurrencerisk
• Lessgoodresponseinthosewith– ahistoryofchildhoodmaltreatment,– mildmaniaatpresentation,– currentdepressioninmothers.
![Page 20: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/20.jpg)
ImprovingMoodWithPsychoanalyticPsychotherapyAndCognitiveBehaviour
Therapy:THEIMPACTSTUDY
TheIMPACTConsortiumIanMGoodyer
ChiefInvestigatorUniversityofCambridge
![Page 21: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/21.jpg)
Whatwereourobjectives
• Whetherpsychologicaltreatmentwas‘goodenough’tomaintainreduceddepressivesymptoms12monthsaftertreatment.
• Ifsowouldthisbecosteffectiveaswellasclinicallyeffective.
• WouldspecialisttreatmentofCBTbesuperiortoshorttermpsychoanalytictherapy(STPP)inachievingtheobjectives.• WouldCBTand/orSTPPbesuperiortothereferencetreatmentofbriefpsychosocialintervention(BPI)
![Page 22: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/22.jpg)
PrinciplesofBriefPsychosocialIntervention
• Collaborativecare.
• Informationexchange.
• Selectedbehaviouralactivation
• Rehabilitationandrecovery.
• Improvingandmaintainingmentalandphysicalhygiene,engaginginpleasurableactivities,maintainingschoolworkandpeerrelationsanddiminishingsolitariness.
![Page 23: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/23.jpg)
ShortTermPsychoanalyticPsychotherapy
• Aimstoincreasethecoherenceoftheyoungperson’smentalmodelsofattachmentrelationships• Therebyimprovecapacityforaffectregulationandtherebythemakingandmaintainingofpositiverelationships.• Techniquesbasedontherelationshipwiththetherapist.
• Explorationofthe'internalworld’experiences:currentpreoccupations,memories,day-dreams,nocturnaldreamsandphantasies.
• Attendingtounconsciousphenomenaisspecifictopsychoanalyticpsychotherapy.
• Thepatient’sexperienceofthetherapistreceiving,holdinginmind,andthinkingaboutprojectedmaterialisacentralfeatureofthetherapy.
![Page 24: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/24.jpg)
CognitiveBehaviourTherapy
• CognitiveBehaviourTherapy(CBT)isbasedontheclassicalformoriginallydevelopedforadultswithdepression.• Pervasiveinformationprocessingbiaseswhichincreasevulnerabilitytodepressioninthecontextofenvironmentalstress.• Thesebiasesmaintainandamplifycoremoodsymptomsofdepression.
• ThefocusofCBTistoidentifytheinformationprocessingbiasesthatmaintaindepressionandlowmoodandtoamendthesethroughaprocessofcollaborativeempiricismbetweenthetherapistandclient.• CBTwasadaptedforthisstudybyincreasingfocusonengagement,useofbehaviouraltechniquesandparentalinvolvement,
![Page 25: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/25.jpg)
TherapyDuration
• BPI:12sessions,(8individual+4family/parent),over20weeks.
• STPP:28sessions(+7parentsessions)over28weeks.
• CBT:Upto20sessionsover30weeks(parentinvolvementifindicated).
![Page 26: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/26.jpg)
ProfessionalsDeliveringTherapy
BPI:ChildandAdolescentPsychiatrists(80%)includingFellowsandChildandAdolescentMentalHealthNurses(20%).CBT:Clinicalpsychologistsorotherprofessionalswithpostqualification
traininginCBTSTPP:Child/AdolescentPsychotherapistsandtraineesintheirlastyear.
![Page 27: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/27.jpg)
Design
ReassessmentsAtthenominal6,12,3652and86week
MDDN=470
BPI12sessions/20weeks
N=155Endofstudy=132
CognitiveBehaviourTherapy20sessions/20weeks
N=154Endofstudy=130
STPP28sessions/30weeks
N=156Endofstudy=119
RandomisedtoOneof3Treatmentarms
MR-IMPACTME-IMPACTGeneticAssayCognitiveAssayCortisolAssay
GoodyerIMetalTrials.2011Jul13;12:175
![Page 28: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/28.jpg)
ParticipantCharacteristics
Characteristic BPI(n=155)Freq.(%)
CBT(n=154)Freq.(%)
STPP(n=156)Freq.(%)
MeanAgeinyrs15.6(1.4) 15.6(1.4) 15.6(1.5)
Females115(74) 114(74) 119(76)
White121(82) 131(86) 130(86)
SSRIbeforetrialentry29(19) 32(21) 28(18)
Mean(MFQ)depressionscore 46.2(10.6) 46.2(10.3) 45.4(10.8)
Interviewerratedsymptoms8.4(2.5) 8.7(2.3) 3. (2.5)
PsychosocialimpairmentScale18.9(6.0) 18.4(6.0) 18.3(6.3)
![Page 29: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/29.jpg)
ParticipantCharacteristicsatBaseline
Characteristic BPI(n=155)Freq.(%)
CBT(n=154)Freq.(%)
STPP(n=156)Freq.(%)
RecentSelfharm26(17) 25(16) 34(22)
LifetimeSelfHarm87(56) 75(49) 84(54)
RecentSuicidalAttempts3(2) 2(1) 7(5)
LifetimeSuicideAttempts57(37) 48(31) 55(35)
Comorbidity(1+)71(46) 80(52) 74(47)
DisruptiveBehaviourDisorders20(13) 20(13) 16(10)
![Page 30: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/30.jpg)
MedianTime(weeks)FromRandomisationToStartingTherapy
BPI CBT STPP
Region Median (95% c.i.) Median (95% c.i.) Median (95% CI)
East Anglia 4.3 (3.3 to 5.6) 7.3 (5.1 to 10.1) 4.7 (3.9 to 5.7)
North London 2.9 (2.0 to 3.7) 4.0 (3.0 to 4.7) 3.9 (2.7 to 4.4)
North West 4.0 (3.1 to 4.6) 4.0 (2.9 to 4.9) 4.4 (3.1 to 6.1)
![Page 31: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/31.jpg)
DurationOfTherapyInWeeks
Treatment Med Max Mean SD N
BPI 22.1 111.9 27.5 21.5 130
CBT 23.1 99.6 24.9 17.7 130
STPP 30.1 97.0 27.9 16.8 131
BPI CBT STPPMedian(IQR)a 6 (4,11) 9 (5,14) 11 (5,23)
Planned 12 20 28
Numberoftherapysessionsattended
![Page 32: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/32.jpg)
Treatmentdifferentiation0
12
34
5BPI CBT STTP
CB Domain PI Domain
CPPS
Doma
in Sc
ore
Graphs by Trial Arm
Measurestakenby2ratersindependentlylisteningtoafixedtimeseriesfrom279audiotapesrandomlyselectedfromthe3armsstratifiedbyage,centreandphaseoftherapy(early,2-4,later>4sessions).MeasuredusingtheCPPSreliability=0.82&0.8perscale.• CBT>STPPon(CB)sub-scalescore(95%CI1·73to2·09,p<0·0001).• STPP>CBTmeanon(PI)sub-scalescore(95%CI1·01to1·3,p<0·0001).• BPI<CBTonCBsub-scale(meandiff.=-0·93,95%CI-1·12to-0·75,p<0·0001)• BPI<STPPonthePIsub-scale(meandiff.=-1·30,95%CI-1·48to-1·11,p<0·0001).• 81%ofBPI,80%ofSTPPand74%ofCBTsessionsmetcriteria
![Page 33: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/33.jpg)
PrevalenceofDepressiveSymptomsAtEntry
0
10
20
30
40
50
60
70
80
90
100
BPI
CBT
STPP
![Page 34: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/34.jpg)
DepressionScoresOverTheStudy
0
5
10
15
20
25
30
35
40
45
50
Baseline 6week 12week 36week 52week 86week
BPI
CBT
STPP
Endoftreatment
MeanMFQ
Score
![Page 35: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/35.jpg)
DepressionSumScoresOverTheStudy20
3040
50Sc
ore
0 20 40 60 80 100Weeks
BPI CBT STPP
ns
![Page 36: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/36.jpg)
IndividualDifferencesinSymptomChange
AverageSymptomChangeovertime
IndividualSymptomChangeovertime
Individualdifferencesinsymptomchangeisevident
020
4060
MFQ
0 20 40 60 80Weeks
20
30
40
0 25 50 75Weeks
MFQ
Female Male
![Page 37: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/37.jpg)
SuicideAttempts&NSSI
0
2
4
6
8
10
12
14
16
18
20
Baseline 6 12 36 52 86
SuicAtmpt
NSSI
Nobetweentreatmentgroupdifferences
![Page 38: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/38.jpg)
SSRIPrescribingOverTheStudy
0
5
10
15
20
25
30
35
40
45
<36wk >=36wk
BPI
CBT
STPP
![Page 39: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/39.jpg)
CostEffectivenessinUKPounds
0
500
1000
1500
2000
2500
3000
3500
Treatment FollowUp Total
BPI(n=90)
CBT(n=92)
STPP(n=91)
UKPo
unds
![Page 40: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/40.jpg)
Summary
• TherearenosuperiorityeffectsofCBToverSTP.
• All3treatmentsarestatisticallyaseffectiveaseachother.
• Allthreetherapiesshowreducedsymptomsayearaftertreatment.
• BPIoffersanadditionalpatientchoiceforpsychologicaltherapy.
• Nocosteffectivenessadvantagebetweenthe3treatmentgroups.
![Page 41: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/41.jpg)
Causality
• Cannotfullydiscountthepossibilitythatalltheobserveddeclineinsymptomsandimprovementinwell-beingwasafunctionoftime.
• Fluoxetinemayacceleratethedeclineinsymptomsacrossthecohortindependentofpsychologicaltreatment.
• Theabsenceofanotreatmentcontrolgrouplimitstheassertionthatanytherapywascausallyeffective.
![Page 42: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/42.jpg)
ConfirmClinicallyDepressedAscertaindiagnosis,obtainselfreportsymptomscores
AssessPredictors/ModeratorsofLikelyTreatmentResponse1.Historyofchildhoodmaltreatment.2.Currentdepressioninaparent.3.Comorbiditiesatpresentation4.Expectationsoftreatment5.Complianceandresponsetopasttreatments.
CollaborativeDiscussion1.Entercollaborativediscussionwithpatientandfamilyaboutdepressionandtreatmentoptions.2.Explainaboutdepressionandanswerallrelevantquestions.3.Explaintreatmentoptionsincludingassociatedrisks.4.Getaplannedtherapeuticsprotocolagreedwithadolescent.5.Offeratimelineforfirstlinetreatment.
TherapeuticActivation1.Firstlinemonotherapycanbepsychological.2.Canbecombinationpsychosocial+fluoxetine.3.Complexcasesmayneedcombinationtherapywithfluoxetineasapriority+psychosocialtreatment.
Therapeuticreview:3-4weeks1. Ispatientalliedwiththerapistandtreatment2. Assessforsideeffects:considertreatment
reluctance,non-complianceandnon-attendanceaspossiblesignsofadverseeffectstotreatment.
3. Furthercollaborativediscussionaboutprogress.
4. Continueorrevisitcurrenttreatmentplan.
TreatmentProgress1. Someimprovementswithanytreatmentby6
weeks.2. 12-18weeksexpectremissioninabout50%
ofcases.3. By24-36weeksexpectremissioninafurther
20-30%.4. Expect10%-20%dropoutby12weeks.5. Expect10%-20%treatmentresistance.6. Noimprovementby6-12weeks-repeatboxD.
A
B
C
D
E
ClinicalAssessment,TreatmentandMonitoring
![Page 43: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/43.jpg)
FutureResearch
• Treatmentresponse.
• Themaintenanceofpositiveeffects.
• Non-response.
• WhetherBPIisofutilityincommunityandprimarycaresettings.
• Fluoxetineeffects.
![Page 44: Treatment of Major Depression In Adolescents - SFBUP · 2018-04-26 · treatment advised for major depression in adolescents March JS et al Arch Gen Psychiatry. 2007 64(10):1132-43.](https://reader033.fdocuments.in/reader033/viewer/2022043015/5f382a90af2c4915ca60c49f/html5/thumbnails/44.jpg)
Acknowledgements
• ThisresearchwasfundedbytheNationalInstituteforHealthResearchHealthTechnologyAssessment(NIHRHTA)programme(projectnumber:06/05/01).
• TheviewsexpressedinthispublicationarethoseoftheauthorsanddonotnecessarilyreflectthoseoftheHTAprogramme,NIHR,NHS,ortheDepartmentofHealth.
• TheongoingresearchisfundedbytheWellcomeTrust,RoyalSocietyandFriendsofPeterhouse.